This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Wall Street Bulls Look Optimistic About Ares Capital (ARCC): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Ares Capital (ARCC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ARCCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ADMANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See AGNC Investment (AGNC) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AGNC Investment (AGNC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AGNCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in MercadoLibre (MELI) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in MercadoLibre (MELI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MELIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in DraftKings (DKNG): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for DraftKings (DKNG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DKNGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Roblox (RBLX): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Roblox (RBLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
RBLXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in PulteGroup (PHM) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PulteGroup (PHM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PHMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Monday.com (MNDY) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Monday.com (MNDY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MNDYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Petrobras (PBR) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Petrobras (PBR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
PBRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See AutoZone (AZO) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AutoZone (AZO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AZOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in CleanSpark (CLSK) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in CleanSpark (CLSK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CLSKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Progressive (PGR) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Progressive (PGR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PGRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Visa (V): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Visa (V) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
VPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Celsius (CELH) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Celsius (CELH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CELHPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Coca-Cola (KO) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Coca-Cola (KO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
KOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Bank of America (BAC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Bank of America (BAC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BACPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VKTXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Shopify (SHOP) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Shopify (SHOP). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SHOPPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Synopsys (SNPS): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Synopsys (SNPS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SNPSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Alibaba (BABA) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Alibaba (BABA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BABAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Applied Materials (AMAT): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Applied Materials (AMAT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AMATPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About CrowdStrike (CRWD): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CrowdStrike (CRWD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRWDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Caterpillar (CAT): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Caterpillar (CAT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CATPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Toll Brothers (TOL): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Toll Brothers (TOL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TOLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth